Search results for "drug resistance"

showing 10 items of 953 documents

Resistance to Gemcitabine in a Lymphoma Cell Line Resistant to Fas-mediated Apoptosis

2004

BACKGROUND: The T-cell lymphoma cell line HuT78B1, selected for resistance to Fas-mediated apoptosis, resulted unexpectedly resistant to the apoptotic and cytotoxic effects of gemcitabine (dFdC). We investigated whether this resistance was due to the impairment of the Fas/Fas-ligand (FasL) system. MATERIALS AND METHODS: dFdC effects were studied in HuT78B1 and in the parental Fas-sensitive HuT78 cells exposed to inhibitors of the Fas/FasL system. RESULTS: FasL- and Fas-blocking antibodies did not interfere with dFdC-induced apoptosis in HuT78 cells, whereas inhibitors of caspase-8, -9, -1 or -3 had partial inhibitory effects. Notably, in HuT78B1 cells there was a markedly reduced dFdC accum…

Antimetabolites AntineoplasticFas Ligand ProteinMembrane GlycoproteinsApoptosisLymphoma T-CellCaspase InhibitorsDeoxycytidineGemcitabineEnzyme ActivationLymphoma T-Cell Cell Line Tumor gemcitabineDrug Resistance NeoplasmCaspasesCell Line TumorDeoxycytidine KinaseHumansfas Receptor
researchProduct

Recent advances in computational design of potent aromatase inhibitors: open-eye on endocrine-resistant breast cancers.

2019

Introduction: The vast majority of breast cancers (BC) are estrogen receptor positive (ER+). The most effective treatments to fight this BC type rely on estrogen deprivation therapy, by inhibiting the aromatase enzyme, which performs estrogen biosynthesis, or on blocking the estrogens signaling path via modulating/degrading the estrogen's specific nuclear receptor (estrogen receptor-?, ER?). While being effective at early disease stage, patients treated with aromatase inhibitors (AIs) may acquire resistance and often relapse after prolonged therapies. Areas covered: In this compendium, after an overview of the historical development of the AIs currently in clinical use, and of the computati…

Antineoplastic Agents Hormonalmedicine.drug_classCYP450sEstrogen receptorallostery; aromatase inhibitors; Breast cancer; CYP450s; ligand-based and structure-based drug design; molecular dynamics; virtual screeningBreast NeoplasmsMolecular Dynamics SimulationBioinformatics03 medical and health sciencesBreast cancer0302 clinical medicineBreast cancerDrug DiscoverymedicineEndocrine systemHumansAromataseSurvival rate030304 developmental biologyCause of deathNeoplasm Staging0303 health sciencesallosterybiologybusiness.industryAromatase Inhibitorsvirtual screeningmedicine.diseaseligand-based and structure-based drug designmolecular dynamicsSurvival RateNuclear receptorEstrogenDrug Resistance Neoplasm030220 oncology & carcinogenesisDrug Designbiology.proteinFemalebusinessExpert opinion on drug discovery
researchProduct

Effects of a glyphosate-based herbicide on survival and oxidative status of a non-target herbivore, the Colorado potato beetle (Leptinotarsa decemlin…

2018

Abstract Glyphosate is the globally most used herbicide against a wide range of weeds. Glyphosate has been considered safe to animals as it mainly targets physiological pathways in plants. However, recent toxicological studies have revealed that glyphosate can cause various toxic effects also on animals. In this study, we investigated the direct toxic effects of a glyphosate-based herbicide (GBH, Roundup® Bio) on 1) survival and 2) oxidative status of a non-target herbivore by using Colorado potato beetles (Leptinotarsa decemlineata), originating from Poland and USA, as model species. Larvae were randomly divided into three groups: 1) high concentration (100% Roundup Bio, 360 g/l), 2) low c…

AntioxidantPhysiologyHealth Toxicology and Mutagenesismedicine.medical_treatmentherbisidit010501 environmental sciencesToxicology01 natural sciencesBiochemistrychemistry.chemical_compoundRandom Allocationantioxidant defenceglyfosaattiinsectsLeptinotarsa0303 health sciencesbiologyGeneral MedicineAdaptation PhysiologicalDrug Resistance MultipleOrganophosphatesColeopteraCatalaseGlyphosateLarvaorganophosphateGlycineSuperoxide dismutase03 medical and health sciencesAnimal scienceglyphosatemedicineAnimalsHerbivoryoksidatiivinen stressipesticide030304 developmental biology0105 earth and related environmental sciencesantioksidantitfosfaatitHerbicidesfungiColorado potato beetleOsmolar Concentrationta1182koloradonkuoriainenPesticide Residuestorjunta-aineetCell BiologyGlutathionePesticidebiology.organism_classificationSurvival AnalysisresistenssiOxidative Stresschemistryhyönteisetbiology.proteinta1181Lipid PeroxidationPolandBiomarkersVermontComparative biochemistry and physiology. Toxicologypharmacology : CBP
researchProduct

Gamma interferon administration differently affects sensitive or doxorubicin resistant P388 leukemia cells; a relationship with antioxidant defenses?

1989

Antioxidantmedicine.medical_treatmentDrug ResistanceDrug resistancePharmacologyBiologyAntioxidantsInterferon-gammaMiceGamma interferonTumor Cells CulturedmedicineAnimalsInterferon gammaDoxorubicinPharmacologyLeukemia ExperimentalLeukemia P388medicine.diseaseGlutathioneIn vitroLeukemiaCytokineDoxorubicinMice Inbred DBAmedicine.drugPharmacological Research
researchProduct

Modulation of P-Glycoprotein-Mediated Multidrug Resistance by Synthetic and Phytochemical Small Molecules, Monoclonal Antibodies, and Therapeutic Nuc…

2014

Multidrug resistance of malignant tumors severely hampers their successful treatment frequently leading to fatal consequences for affected patients. During the past three decades, many efforts have been spent to develop strategies to overcome multidrug resistance. Many chemical compounds have been shown to inhibit the drug efflux of the multidrug-resistance-mediating P-glycoprotein. Chemical P-glycoprotein inhibitors are from the classes of calcium channel antagonists, calmodulin inhibitors, cyclosporins, antiarrhythmics, hormones, antimalarials, antibiotics, detergents, beta-blockers, antidepressants, blood pressure lowering indol alkaloids, aerobic glycolysis inhibitors, HIV-protease inhi…

Antisense therapyDrugbiologymedicine.drug_classgovernment.form_of_governmentmedia_common.quotation_subjectContext (language use)Drug resistanceMonoclonal antibodyMultiple drug resistanceBiochemistrybiology.proteingovernmentmedicineEffluxP-glycoproteinmedia_common
researchProduct

Total Synthesis and Biological Investigation of (−)‐Artemisinin: The Antimalarial Activity of Artemisinin Is not Stereospecific

2018

Here, we describe an efficient and diversity-oriented entry to both (-)-artemisinin (1) and its natural antipode (+)-artemisinin, starting from commercially and readily available S-(+)- and R-(-)-citronellene, respectively. Subsequently, we answered the still open question regarding the specificity of artemisinins action. By using a drug-sensitive Plasmodium falciparum NF54 strain, we showed that the antimalarial activity of artemisinin is not stereospecific. Our straightforward and biomimetic approach to this natural endoperoxide enables the synthesis of artemisinin derivatives that are not accessible through applying current methods and may help to address the problem of emerging resistan…

ArtemisininsCell SurvivalPlasmodium falciparum010402 general chemistry01 natural sciencesCatalysisAntimalarialsStereospecificityCell Line Tumorparasitic diseasesmedicineHumansArtemisininbiology010405 organic chemistryChemistryTotal synthesisStereoisomerismPlasmodium falciparumGeneral Chemistrybiology.organism_classificationCombinatorial chemistryArtemisinins0104 chemical sciencesCyclizationDrug Resistance NeoplasmMonoterpenesmedicine.drugAngewandte Chemie International Edition
researchProduct

Azole-resistant Aspergillus fumigatus: A global phenomenon originating in the environment?

2019

Abstract Aspergillus fumigatus is the predominant etiological agent of invasive aspergillosis (IA), a difficult-to-manage fungal disease associated with a high case fatality rate. Azole antifungals, particularly voriconazole, have significantly improved the survival rate of patients with IA. However, the clinical advances made possible through the use of medical azoles could be threatened by the emergence of azole-resistant strains which has been reported in an ever-increasing number of countries over the last 10 years. The major resistance mechanism, that combines point mutation(s) in the coding sequence of cyp51A gene and an insertion of a tandem repeat in the promoter region of this gene…

AzolesAntifungal AgentsGenotypeMicrobial Sensitivity TestsGene mutationAspergillosisAspergillus fumigatusMicrobiologyFungal Proteins03 medical and health sciencesDrug Resistance FungalmedicineAspergillosisHumansGeneComputingMilieux_MISCELLANEOUSchemistry.chemical_classificationVoriconazole[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/Health0303 health sciencesbiology030306 microbiologyPoint mutationAspergillus fumigatusbiology.organism_classificationmedicine.disease3. Good healthInfectious DiseaseschemistryAzoleEffluxVoriconazolemedicine.drug
researchProduct

On the Emergence of Candida auris: Climate Change, Azoles, Swamps, and Birds

2019

The most enigmatic aspect of the rise of Candida auris as a human pathogen is that it emerged simultaneously on three continents, with each clade being genetically distinct. Although new pathogenic fungal species are described regularly, these are mostly species associated with single cases in individuals who are immunosuppressed.The most enigmatic aspect of the rise of Candida auris as a human pathogen is that it emerged simultaneously on three continents, with each clade being genetically distinct. Although new pathogenic fungal species are described regularly, these are mostly species associated with single cases in individuals who are immunosuppressed. In this study, we used phylogeneti…

AzolesAntifungal AgentsLetterZoologyClimate changeHuman pathogenClose relativesMicrobial Sensitivity TestsFungusBiologyCommunicable Diseases EmergingSwampMicrobiologyBirds03 medical and health sciencesDrug Resistance Multiple FungalVirologyAnimalsHumansCladePhylogeny030304 developmental biologyCandida0303 health sciencesgeographygeography.geographical_feature_categoryPhylogenetic tree030306 microbiologyfungusCandidiasisTemperaturebiology.organism_classificationQR1-502Fungal diseaseclimate changeCandida auris13. Climate actionmBio
researchProduct

Interaction of Bacillus thuringiensis Toxins with Larval Midgut Binding Sites of Helicoverpa armigera (Lepidoptera: Noctuidae)

2004

ABSTRACT In 1996, Bt-cotton (cotton expressing a Bacillus thuringiensis toxin gene) expressing the Cry1Ac protein was commercially introduced to control cotton pests. A threat to this first generation of transgenic cotton is the evolution of resistance by the insects. Second-generation Bt-cotton has been developed with either new B. thuringiensis genes or with a combination of cry genes. However, one requirement for the “stacked” gene strategy to work is that the stacked toxins bind to different binding sites. In the present study, the binding of 125 I-labeled Cry1Ab protein ( 125 I-Cry1Ab) and 125 I-Cry1Ac to brush border membrane vesicles (BBMV) of Helicoverpa armigera was analyzed in com…

Bacterial ToxinsPopulationBacillus thuringiensisCarbohydratesDrug ResistanceHelicoverpa armigeraModels BiologicalApplied Microbiology and BiotechnologyMicrobiologyHemolysin Proteinschemistry.chemical_compoundBacterial ProteinsLectinsBacillus thuringiensisInvertebrate MicrobiologyAnimalsBinding siteSoybean agglutininPest Control BiologicaleducationGossypiumeducation.field_of_studyBinding SitesBacillus thuringiensis ToxinsEcologybiologyfungifood and beveragesPlants Genetically Modifiedbiology.organism_classificationSialic acidEndotoxinsLepidopteraKineticsCry1AcchemistryBiochemistryGenes BacterialLarvaNoctuidaeDigestive SystemFood ScienceBiotechnologyApplied and Environmental Microbiology
researchProduct

Type-IIA secreted phospholipase A2 is an endogenous antibiotic-like protein of the host.

2010

International audience; Type-IIA secreted phospholipase A(2) (sPLA(2)-IIA) has been proposed to play a role in the development of inflammatory diseases. It has been shown to release arachidonic acid, the precursor of proinflammatory eicosanoids, to hydrolyze phospholipids of pulmonary surfactant, and to bind to specific receptors located on cell surface membranes. However, the most established biological role of sPLA(2)-IIA is related to its potent bactericidal property in particular toward Gram-positive bacteria. This enzyme is present in animal and human biological fluids at concentrations sufficient to kill bacteria. Human recombinant sPLA(2)-IIA is able to kill Gram-positive bacteria at…

Bacterial Toxinsmedicine.disease_causeGroup II Phospholipases A2BiochemistryMicrobiologyAnthraxMice03 medical and health scienceschemistry.chemical_compound0302 clinical medicineImmune systemPhospholipase A2PhosphatidylcholinemedicineAnimalsHumansEscherichia coli030304 developmental biologyAntigens Bacterial0303 health sciencesPhospholipase AArachidonic AcidbiologyDrug Resistance MicrobialPathogenic bacteriaGeneral Medicinebiology.organism_classificationAnti-Bacterial Agents3. Good healthBacillus anthracisBiochemistrychemistryBacillus anthracisHost-Pathogen Interactionsbiology.protein[SDV.IMM.VAC]Life Sciences [q-bio]/Immunology/VaccinologyBacteria030215 immunology
researchProduct